Douglas D. Watts

Array ( [id] => 4080990 [patent_doc_number] => 06017510 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-25 [patent_title] => 'Technetium-99M labeled peptides for imaging inflammation' [patent_app_type] => 1 [patent_app_number] => 8/266178 [patent_app_country] => US [patent_app_date] => 1994-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5662 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/017/06017510.pdf [firstpage_image] =>[orig_patent_app_number] => 266178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3587940 [patent_doc_number] => 05585244 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Detection of retinoid X receptor subtype .gamma. proteins' [patent_app_type] => 1 [patent_app_number] => 8/258851 [patent_app_country] => US [patent_app_date] => 1994-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 24 [patent_no_of_words] => 8765 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585244.pdf [firstpage_image] =>[orig_patent_app_number] => 258851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4101003 [patent_doc_number] => 06051384 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Method of detecting p53-specific antibodies' [patent_app_type] => 1 [patent_app_number] => 8/244476 [patent_app_country] => US [patent_app_date] => 1994-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8291 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051384.pdf [firstpage_image] =>[orig_patent_app_number] => 244476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4098827 [patent_doc_number] => 06066463 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Method and compositions for treatment of BCR-ABL associated leukemias and other cell proliferative disorders' [patent_app_type] => 1 [patent_app_number] => 8/246441 [patent_app_country] => US [patent_app_date] => 1994-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 22 [patent_no_of_words] => 23355 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066463.pdf [firstpage_image] =>[orig_patent_app_number] => 246441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621322 [patent_doc_number] => 05601988 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Immunocapture assay for cancer procoagulant antibody complex in biological samples' [patent_app_type] => 1 [patent_app_number] => 8/246840 [patent_app_country] => US [patent_app_date] => 1994-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6946 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/601/05601988.pdf [firstpage_image] =>[orig_patent_app_number] => 246840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3645058 [patent_doc_number] => 05637465 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Method for the detection of a programmed or induced cell death of eukaryotic cells' [patent_app_type] => 1 [patent_app_number] => 8/245583 [patent_app_country] => US [patent_app_date] => 1994-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2504 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637465.pdf [firstpage_image] =>[orig_patent_app_number] => 245583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4029893 [patent_doc_number] => 05942230 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'Composition of immunotoxins and retinoids and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/238997 [patent_app_country] => US [patent_app_date] => 1994-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 23 [patent_no_of_words] => 11990 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942230.pdf [firstpage_image] =>[orig_patent_app_number] => 238997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1580021 [patent_doc_number] => 06423313 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'Inhibition of tumor growth by blockade of the protein C system' [patent_app_type] => B1 [patent_app_number] => 08/238987 [patent_app_country] => US [patent_app_date] => 1994-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 10102 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423313.pdf [firstpage_image] =>[orig_patent_app_number] => 08238987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3871706 [patent_doc_number] => 05824488 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Immortalized and malignant human prostatic cell lines' [patent_app_type] => 1 [patent_app_number] => 8/234843 [patent_app_country] => US [patent_app_date] => 1994-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6596 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824488.pdf [firstpage_image] =>[orig_patent_app_number] => 234843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3655379 [patent_doc_number] => 05658743 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Antibody to antigen specifically expressed on the surface of B cells and Hodgkin\'s cells' [patent_app_type] => 1 [patent_app_number] => 8/229364 [patent_app_country] => US [patent_app_date] => 1994-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 14823 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658743.pdf [firstpage_image] =>[orig_patent_app_number] => 229364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3604416 [patent_doc_number] => 05578701 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'ppRB.sup.110 - nuclear phosphoprotein - the retinoblastoma susceptibility gene product' [patent_app_type] => 1 [patent_app_number] => 8/225099 [patent_app_country] => US [patent_app_date] => 1994-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9953 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578701.pdf [firstpage_image] =>[orig_patent_app_number] => 225099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3947215 [patent_doc_number] => 05955291 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Antibodies recognizing tie receptor tyrosine kinase and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/220240 [patent_app_country] => US [patent_app_date] => 1994-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11391 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955291.pdf [firstpage_image] =>[orig_patent_app_number] => 220240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4176461 [patent_doc_number] => 06037134 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Methods that detect compounds that disrupt receptor tyrosine kinase/GRB-7 complexes' [patent_app_type] => 1 [patent_app_number] => 8/207575 [patent_app_country] => US [patent_app_date] => 1994-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 25776 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037134.pdf [firstpage_image] =>[orig_patent_app_number] => 207575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693171 [patent_doc_number] => 05650287 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Method of assaying for the oncogenic state of cells' [patent_app_type] => 1 [patent_app_number] => 8/196907 [patent_app_country] => US [patent_app_date] => 1994-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 7536 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650287.pdf [firstpage_image] =>[orig_patent_app_number] => 196907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3824675 [patent_doc_number] => 05783403 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Malignant cell type markers of the interior nuclear matrix' [patent_app_type] => 1 [patent_app_number] => 8/195487 [patent_app_country] => US [patent_app_date] => 1994-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 12457 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783403.pdf [firstpage_image] =>[orig_patent_app_number] => 195487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3620299 [patent_doc_number] => 05593847 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Monitoring of NC 50/90 in blood samples of breast cancer patients' [patent_app_type] => 1 [patent_app_number] => 8/170141 [patent_app_country] => US [patent_app_date] => 1993-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 5553 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593847.pdf [firstpage_image] =>[orig_patent_app_number] => 170141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3606867 [patent_doc_number] => 05589345 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Cultures of permanent lines of human promyelocytic cells and their uses for the screening of molecules utilizable in particular in the treatment of leukemias' [patent_app_type] => 1 [patent_app_number] => 8/108587 [patent_app_country] => US [patent_app_date] => 1993-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4895 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589345.pdf [firstpage_image] =>[orig_patent_app_number] => 108587 [rel_patent_id] =>[rel_patent_doc_number] =>)